There is no official link established between semaglutide and direct hormonal disruption of the menstrual cycle
Areas of theoretical concern include: Glycaemic instability , particularly in those on antidiabetic medications Altered lipid metabolism , given GH's effects on fatty acid mobilisation Indirect cardiovascular effects , as elevated heart rate has been observed with glucagon receptor agonism and fluid retention is associated with GH excess [1] [17] There are no formal interaction data linking retatrutide and sermorelin to specific adverse outcomes, but the absence of evidence must not be interpreted as confirmation of safety
Assaf et al., 2020)
Related products Laboratories studying copper-peptides and repair-associated sequences alongside GHK-Cu frequently stock BPC-157 5 MG, MOTS-C 10 MG, PRL-RT3 10 MG, and PRL-T2 10 MG
The objective of this study was to describe the temporal patterns of GLP-1 RA switching from 2018 to 2023, as well as demographic characteristics of patients who switched
Dr Lovshin, Clinician Investigator and Assistant Professor of Medicine in the Division of Endocrinology and Metabolism, in the Temetry Department of Medicine at the University of Toronto
)
